Navigation Links
HCA Appoints Dr. Richard Tayrien Chief Health Information Officer
Date:9/2/2009

NASHVILLE, Tenn., Sept. 2 /PRNewswire/ -- HCA today announced Dr. Richard Tayrien will become the company's Chief Health Information Officer, a new position, effective September 21.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO )

Tayrien, 56, will report to Dr. Jonathan B. Perlin, President of HCA's Clinical Services Group and Chief Medical Officer. He will lead an expanding team of clinicians and informaticists and be responsible for the continued development and implementation of hCare, HCA's comprehensive program for advanced health information technologies. HCA's hCare builds on foundational electronic health record functions and will include computerized provider order entry and decision support. HCA is already among the 15% of American hospitals that use bar-code medication administration systems. HCA's hCare also integrates outpatient treatment into the electronic health record, and will include patient health records that capture health information from visits to doctors.

"During his 25 years in medicine, Dr. Tayrien has proven to be an innovator and gifted leader," said Perlin. "He has extensive experience creating and deploying clinical information systems that promote quality and efficiency and improve patient safety. We are very pleased to welcome him to HCA."

Currently, Tayrien is Vice President, Clinical Information Systems for Catholic Healthcare West, where he is responsible for strategy, development and implementation of clinical information systems. He previously was Regional Medical Director for Clinical Informatics at St. Joseph's Hospital and Medical Center/Barrow Neurological Institute. Tayrien practiced internal medicine for the first 18 years of his career.

Tayrien recently served on
'/>"/>

SOURCE HCA
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO
2. Spodak Dental Group Appoints Prominent Anesthesiologist to Oversee All I.V. Sedation Dental Cases
3. Insulet Appoints Peter J. Devlin as Chief Commercial Officer
4. PMSI Appoints Lori Daugherty as President of Pharmacy Division
5. St. Jude Appoints New Senior Vice President of Public Relations
6. Bill & Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office
7. WorldHeart Appoints Morgan Brown as New Vice President of Finance and Chief Financial Officer
8. El.En. Group Establishes New Subsidiary, DEKA Medical, Inc. and Appoints Management Team
9. iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board
10. Streamline Health Appoints Jon Phillips Chairman of the Board of Directors
11. Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... The Special Olympics Missouri State Summer Games will bring more ... Columbia. This state-level event takes place May 30-June 2, on ... and at Hickman High School and Town & Country Lanes. ... 7:30 p.m. Friday, May 30 with the Opening Ceremony. The ... of Athletes, the culmination of the statewide Law Enforcement Torch ...
(Date:5/21/2013)... significantly more likely than their normal-weight counterparts to ... disrupts continuity of care and leads to more ... , The practice of "doctor shopping" among overweight ... with the health care system, whether that be ... advice by providers, or improperly sized medical equipment ...
(Date:5/21/2013)... May 21, 2013 Children using ... Sophono, Inc., experience audiological results comparable to the ... many fewer complications, according to a new study. ... that Sophono’s abutment-free technology performs just as well ... with many fewer complications,” says Jim Kasic, president ...
(Date:5/21/2013)... 21 (HealthDay News) -- Urban elementary school children ... sleep problems and suffer academically, new research indicates. ... seven to nine, we found that compromised lung ... impaired academic performance," said study author Daphne ... behavior at Brown University,s Alpert Medical School in ...
(Date:5/21/2013)... Positively charged gold nanoparticles are usually toxic to ... nanoparticle toxicity. Mayo Clinic researchers found out why, ... against ovarian cancer cells. The discovery is detailed ... Journal of Biological Chemistry ., "This study identifies ... by preventing the cell death or apoptosis which ...
Breaking Medicine News(10 mins):Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2
... Healing Ministry, who is a self-proclaimed AIDS healer, was ... of Sh1.6 million.// The money was obtained by telling ... through prayers. ,The Nairobi Principal Magistrate, Margaret ... officer, Patrick Nyale said that many more people were ...
... tobacco by youngsters will cost their dear lives and India ... a year, which will greatly affect the country’s economic growth//, ... tobacco users and more than 900,000 people succumb to tobacco-related ... number of youths falling prey to the addiction. ...
... to treat diabetic nerve damage has shown promising results. A ... when injected into the system, it was found to trigger ... and feet – diabetic neuropathy. ,The positive ... further evidence that the research could lead to a new ...
... falling standards of cleanliness despite Government promises to clean ... in 2002, only 52 percent reported about clean wards. ... very clean, but only 46 percent this year. Contradicting ... levels of general satisfaction with the health service. ...
... to a report by the public services watchdog, the hospitals ... of patients with potentially// fatal condition known as ‘Deep vein ... usually in the leg. ,An enquiry that was ... died from DVT, found that the failure to diagnose the ...
... reputation to disagree with any other form of treatment. But to ... to have a better life//. ,A resident artist much ... Scotland.,The lady in question is Susan Grant, a graduate of the ... coming by the Scottish Arts Council. ,It is one ...
Cached Medicine News:Health News:Tobacco Consumption By Youths Will Hamper India’s Economic Growt 2Health News:New Gene Therapy Treats Diabetic Neuropathy 2Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2
(Date:5/21/2013)... , May 21, 2013 Reportlinker.com ... is available in its catalogue: ... Reimbursement Scenario for Medical Devices in the ...   Changing Regulatory and ... US Market   ...
(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... ), a specialty pharmaceutical company focused on ... for the treatment of acute and breakthrough ... in a placebo-controlled Phase 3 study of ... analgesia) System (NanoTab System), the primary efficacy ...
(Date:5/21/2013)... N.C. and HENDERSONVILLE, N.C. ... Medicare bidding procurement program for home medical equipment ... North Carolina to lay off employees ... the quality of service and products received by Medicare ... Under the defective and dangerous program, the Centers ...
Breaking Medicine Technology:Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4
... Dec. 22 Mylan Inc. (Nasdaq: MYL ) today ... approval from the U.S. Food and Drug Administration (FDA) under ... New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 ... form were developed by Matrix for use in treating pediatric ...
... , , , , ... announced that it has entered into an agreement with Laboratoires ... lipase. , DSM has successfully completed process development and commenced ... and Phase I clinical needs. DSM BioSolutions manufactures the lipase ...
Cached Medicine Technology:Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets 2DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 2DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 3DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 4
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0454....
For use with catalog #0454....
Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....
Medicine Products: